Gonadotropin-releasing hormone agonist plus ''add-back'' hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial

By Franke H.R.   van de Weijer P.H.M.   Pennings T.M.M.   van der Mooren M.J.  

Fertility and Sterility, Vol. 74, Iss. 3, 2000-09 ,pp. : 534-539

Elsevier

Access to resources Recommend Favorite

Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (''draw-back'' therapy)

By Tahara M.   Matsuoka T.   Yokoi T.   Tasaka K.   Kurachi H.   Murata Y.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 799-804

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma

By Higashijima T.   Kataoka A.   Nishida T.   Yakushiji M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 169-173

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial

By Vercellini P.   Trespidi L.   Zaina B.   Vicentini S.   Stellato G.   Crosignani P.G.  

Fertility and Sterility, Vol. 79, Iss. 6, 2003-06 ,pp. : 1390-1395

Elsevier

Access to resources Recommend Favorite

The comparison of gonadotropin-releasing hormone agonist therapy and intraperitoneal Ringer's lactate solution in prevention of postoperative adhesion formation in rat models

By Canbaz M.A.   Ustun C.   Kocak I.   Yanik F.F.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 82, Iss. 2, 1999-02 ,pp. : 219-222

Elsevier

Access to resources Recommend Favorite